6533b820fe1ef96bd1279ca0
RESEARCH PRODUCT
Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action
Manfredi RizzoDomenico CianfloneFrancesco MarantaLorenzo Cianfanellisubject
Blood GlucoseAmerican diabetes associationmedicine.medical_specialtybusiness.industryLow density lipoprotein cholesterolCardiovascular outcome trials Cardiovascular prevention Cardiovascular risk Diabetes mellitus type 2 Glucose-lowering drugs Therapeutical targets Blood Glucose Humans Hypoglycemic Agents Cardiovascular Diseases Diabetes Mellitus Type 2 Sodium-Glucose Transporter 2 InhibitorsCall to actionProprotein Convertase Subtilisin/Kexin 9Diabetes Mellitus Type 2Cardiovascular preventionCardiovascular DiseasesHumansHypoglycemic AgentsMedicineCardiology and Cardiovascular MedicinebusinessIntensive care medicineSodium-Glucose Transporter 2 InhibitorsGlycated haemoglobinyear | journal | country | edition | language |
---|---|---|---|---|
2020-12-29 |